| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Health Care
| Amgen is actively enhancing its product development pipeline, particularly in the fields of autoimmune diseases and obesity, with new drugs showing promising market potential. The effective collaboration with AstraZeneca has led to notable advancements in cancer treatment, underscoring Amgen's commitment to impactful therapies. Additionally, ongoing product launches and developments are seen as key catalysts for growth, positively influencing investor sentiment. However, the competitive landscape in the drug market remains a challenge that the company must navigate carefully. |
| The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 2.1 is extremely bullish. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. AMGN is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.2, and the negative at -0.3 on 2026-11-02. The forces of Sentiment towards Fundamentals (3), Stock Price Trend (2.1), Option Sentiment (1.5), and Sector Price Trend (1.3) will drive up the price. The forces of Valuation Sentiment (-0.1), Price Level Sentiment (-0.5), and Market Risk Appetite (-1.4) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| AMGN | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-02 | 0%(0%) | 467.22 | 4.18% | 93 | 80 | 38 | 0.18% | 0.94% | 2.1 | 0 | 0.8% | 0.9 | Long | 55% | 3 | 6 |
| 2026-11-01 | 0%(0%) | 2.1 | 0 | 0.4 | 1.9 | -1 | ||||||||||
| 2026-10-31 | 0%(0%) | 2.1 | 0 | 0.7 | 2.4 | 7 | ||||||||||
| 2026-10-30 | 0%(0%) | 466.4 | 4.08% | 97 | 80 | 61 | 1.22% | 0.77% | 2.1 | 0.2 | 1.5% | 0.9 | Long | 70% | 3.1 | -1 |
| 2026-10-29 | 0%(0%) | 460.78 | 3.86% | 96 | 81 | 64 | 2.09% | 0.57% | 1.4 | 0.5 | 1.2% | 1 | Wait | 50% | 3 | -1 |
| 2026-10-28 | 0%(0%) | 451.35 | 3.57% | 89 | 73 | 65 | 0.74% | 0.59% | 1.2 | 0.3 | 0.7% | 0.7 | Long | 55% | 3.1 | -1 |
| 2026-10-27 | 0%(0%) | 448.04 | 3.35% | 89 | 75 | 74 | 0.86% | 0.69% | 1.4 | 0.2 | 0.7% | 1.3 | Long | 55% | 3.7 | -1 |
| 2026-10-26 | 0%(0%) | 444.22 | 3.17% | 88 | 74 | 52 | 0.99% | 0.7% | 1.5 | 0.2 | 0.7% | 1.1 | Long | 65% | 3.9 | -1 |
| 2026-10-25 | 0%(0%) | 1.4 | 0.2 | 1.5 | 3.4 | -1 | ||||||||||
| 2026-10-24 | 0%(0%) | 1.4 | 0.2 | 1.5 | 3.2 | 7 | ||||||||||
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| 2026-11-02 17:04:13 The competition among pharmaceutical giants is intensifying as they strive to meet or exceed earnings forecasts, reflecting a challenging market landscape. |
| 2026-11-02 17:04:13 The pharmaceutical industry is experiencing significant shifts as companies prepare for earnings reports, influenced by drug demand and competition. |
| 2026-11-02 17:04:13 Amgen's slight increase in stock price reflects ongoing investor confidence and market performance amidst earnings forecasts. |
| 2026-11-02 17:04:13 Recent advancements in drug treatments, specifically the combination of Amgen's Imdelltra and AstraZeneca's Imfinzi, showcase positive outcomes in cancer treatment. |
| 2026-11-02 17:04:13 The upcoming Q3 earnings reports for major pharmaceutical companies indicate a critical juncture, highlighting the expectations for strong performance. |
| 2026-11-02 13:47:00 The mention of a potential catalyst for Amgen's share prices signifies an ongoing development in the company that could enhance its market value. |
| 2026-11-02 13:47:00 The article highlights that Amgen operates in a booming healthcare sector, suggesting a favorable environment for growth and investment. |
| 2026-11-02 13:47:00 The article discusses the potential for increased value in Amgen's shares, indicating strong performance in the stock market. |
| 2026-11-02 09:34:15 The focus on breaking into the obesity drug market highlights the competitive landscape Amgen must navigate in the pharmaceutical industry. |
| 2026-11-02 09:34:15 The research collaboration at the University of Iceland signifies a strong partnership in the development of new pharmaceutical solutions. |
| 2026-11-02 09:34:15 The article discusses Amgen's efforts to develop a new obesity drug, indicating a positive outlook on the potential market growth in this area. |